SuperLife Growth

SuperLife Growth charges a total fee of 0.61 per cent, landing it among the cheaper options in a category where costs vary widely and every basis point counts over decades of compounding.

The fund holds 76 per cent in growth assets, split between 52.5 per cent international shares and 18.8 per cent Australasian equities. It builds most of its offshore exposure through exchange-traded funds rather than direct stock picks, though the biggest US tech names still surface: NVIDIA at 2.75 per cent, Apple at 2.48 per cent, Microsoft at 1.74 per cent. The top holding is an infrastructure ETF hedged to the Australian dollar at 4.69 per cent, followed by a global property fund at 4.06 per cent. Fisher & Paykel Healthcare is the sole New Zealand stock in the top ten, weighted at 1.6 per cent. Over five years the fund returned 7.8 per cent annually and placed 7th in its category. The one-year return of 11.8 per cent sits at 9th.

At $83.7 million in funds under management, SuperLife Growth remains modest in scale. The structure is straightforward: a growth fund built for long time horizons, delivered through low-cost passive building blocks and a light touch on individual stock concentration.

General information only, not financial advice. Past performance is not a reliable indicator of future results.